UK will participate to European research programmes
by Giuliana Miglierini The divergent road opened as a consequence of the Brexit, in January 2021, between the…
The New Pharmaceutical Legislation
by Jane Nicholson To celebrate the 70th Anniversary of the foundation of the Belgian Association of Industrial Pharmacists…
The debate on the “Do No Significant Harm” principle in R&D
by Giulianna Miglierini The “Do No Significant Harm” (DNSH) principle is a widely diffused approach aimed to guarantee…
The proposals of the EU Commission for the revision of the IP legislation
By Giuliana Miglierini In parallel to the new pharmaceutical legislation, on 27 April 2023 the EU Commission issued…
The EU Commission proposal of the new pharmaceutical legislation
By Giuliana Miglierini After a five-months delay, the European Commission has announced on 26 April 2023 its proposal…
HERA reports on stockpiling of antimicrobials
By Giuliana Miglierini The European Health Emergency Preparedness and Response Authority (HERA) has published the two final reports,…